STAT+: European VCs band together to improve the landscape for biotech startups

STAT+: Biotech investors’ plea to Trump, and a busy M&A week

STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch

STAT+: ‘Takeover Tuesday’ saves biotech’s quarter

STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts

STAT+: Trump administration prepares 100% tariffs on some imported drugs

STAT+: Makary marks one year at FDA with focus on achievements in speech to staff

STAT+: Large AI scribe study finds modest time savings, inconsistent use

STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more

STAT+: Insilico Medicine CEO on how best to use AI in drug development

STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups

STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more

STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome

STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more

STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more